Executive Management

Tobin “Toby” Schilke joined Crinetics as chief financial officer in February 2025. Prior to joining Crinetics, Mr. Schilke served as Chief Financial Officer at Revance Therapeutics between 2018-2025. Mr. Schilke served as Chief Financial Officer at Achaogen 2016-2018. Earlier in his career, he spent more than a decade at Roche/Genentech.

Mr. Schilke holds a bachelor’s degree in chemical engineering from Lafayette College, a master’s degree in chemical engineering from the University of California, Berkeley, and a master’s degree in business administration from Cornell University.